Danaher | DHR - Ebitda


Danaher reported $2.1B in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Agilent USD 577M 77M Jun/2026
Align Technology USD 232.86M 3.72M Jun/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Bio Techne USD 115.94M 763K Jun/2026
Bio-Rad Laboratories USD 595.3M 1.23B Jun/2026
Boston Scientific USD 1.63B 27M Jun/2026
Bruker USD 143.2M 33.2M Jun/2026
Charles River Laboratories USD 272.95M 43.14M Jun/2026
Danaher USD 2.1B 257M Sep/2026
Dentsply International USD 190M 61M Jun/2026
Edwards Lifesciences USD 555.6M 485.5M Mar/2026
ESCO Technologies USD 83.76M 7.38M Jun/2026
Fortive USD 338.8M 15.4M Sep/2026
Henry Schein USD 288M 1000K Jun/2026
Illumina USD 330M 80M Jun/2026
Intuitive Surgical USD 1.2B 147.7M Jun/2026
IQVIA Holdings USD 1.03B 38M Sep/2026
Keysight Technologies USD 718M 168M Jun/2026
Laboratory Of America USD 674.3M 93.4M Sep/2026
Medtronic USD 2.63B 174M Jun/2026
Mettler Toledo International USD 322.64M 43.66M Jun/2026
Myriad Genetics USD 14.3M 4M Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Quest Diagnostics USD 627M 21M Sep/2026
Quidel USD 129.3M 20.6M Jun/2026
Repligen USD 43.84M 70K Sep/2026
Revvity USD 228.18M 44.73M Jun/2026
Roper Industries USD 1.65B 685.3M Jun/2026
Stryker USD 1.93B 357M Jun/2026
Thermo Fisher Scientific USD 3.79B 244M Sep/2026
Waters USD 712M 545M Jun/2026
Zimmer Biomet Holdings USD 830.5M 190.4M Jun/2026